

Can We Wait To Take The Economic Loss On Weight Loss
Mar 29, 2024
Jonathan Gruber, Chairman of the Economics Department at MIT discusses the affordability of weight loss drugs like Ozempic in a world where Miracle Weight-Loss Drugs could impact millions. The podcast also delves into the economic implications, government involvement, and ethical considerations surrounding the accessibility and funding of weight loss medications. Additionally, the episode touches on the legal troubles of My Pillow CEO, Mike Lindell, and the societal perspectives on health policies related to weight loss.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Introduction
00:00 • 4min
Navigating Healthcare Challenges and Treatment Costs
04:28 • 8min
Exploring the Impact and Potential of Drugs on Weight Loss and Cravings
12:52 • 2min
Navigating the Economics of Weight Loss Drugs
14:45 • 13min
Economic Evaluation of Health Improvements and Drug Pricing
28:03 • 3min
Navigating the Complexities of Valuing Life and Happiness
31:14 • 11min
Exploring Public Opinion on Government Health Policies and Expertise
41:58 • 2min